Zdrowie i gospodarka · 14/08/2013
FDA Transfers Oversight of Live Cell Wound Care Products to CBER
The FDA is consolidating its oversight of wound care products containing live cells, transferring responsibility from CDRH to CBER, to improve coordination and efficiency in regulatory activities.